精鼎医药

Parexel Chief Information Officer, Jonathan Shough, joined Ben Fanning on Hexaware Technologies' CEO Tech Live podcast to discuss the evolving role of technology leaders in today's business landscape. Jonathan emphasizes the importance of navigating complexities through proactive planning and adaptability, particularly in the face of unexpected challenges: “Plan for the eventuality…how are we going to react to it? If you wait until you're in the suit, it's going to be really difficult." Listen to the full episode for Jonathan's insights on leadership and stay tuned for the video interview! https://lnkd.in/dZK-2K3R ? #ChampionsofChange #CEOTechLive #PoweredByHexaware #ClinicalTrials

?? We're thrilled to announce Parexel is a finalist for "Best Contract Research Organization" at the 3rd annual Citeline Japan Awards! The #CitelineJapan Awards celebrate outstanding innovations in Japanese pharma and biotech, highlighting Japan's crucial role in global healthcare. This nomination underscores Parexel's commitment to advancing clinical research and drug development in Japan and we're honored to be recognized among the leading innovators in our field. Winners will be announced Oct. 22 in Tokyo. Stay tuned for the results! https://lnkd.in/gqNyeeBd ?? パレクセルが第3回サイトライン?ジャパン?アワードの「Best Contract Research Organization」のファイナリストに選ばれたことをお知らせします！ サイトライン?ジャパン?アワード #CitelineJapan Awardsは、日本の製薬およびバイオテクノロジーにおける卓越したイノベーションを称え、世界のヘルスケアにおける日本の重要な役割をハイライトするものです。今回のノミネートは、日本における臨床研究と医薬品開発の推進に対するパレクセル社のコミットメントを裏付けるものであり、この分野における主要なイノベーターの一社として評価されたことを光栄に思います。 受賞企業は10月22日に東京で発表されます！https://lnkd.in/gqNyeeBd #CitelineAwards #ClinicalResearch

Be sure to tune in to a special edition of the #BioCenturyThisWeek podcast. Our own Gwyn Bebb, SVP, Global Therapeutic Area Head - Oncology, shares his insights coming out of #ESMO24, reflecting on the transformative journey of immunotherapy over the past decade, the promising future of mRNA vaccines in cancer treatment and the innovative strides in radiopharmaceuticals. ?? Don't miss this engaging conversation that bridges the worlds of oncology and innovation. https://lnkd.in/gEtXqAHf #BioCenturyPodcast #Oncology #CancerResearch #ClinicalTrials

In the latest episode of the #ParexelBiotech podcast series, "De-Risking Drug Development," we focus on the pre-approval phase of drug development, where commercial launch planning should be started 2 - 3 years before marking authorization. Learn why it's critical to start early and approaches biotechs should be implementing, especially those with a first-time launch. Our experts provide practical examples of how to build and embed launch excellence, focusing on actionable insights to mitigate risk at this stage in the product lifecycle. Create success by planning for it. Listen now: https://lnkd.in/gTRimaPk #DrugDevelopment #Biotech #LaunchExcellence #ClinicalDevelopment

The World Drug Safety Congress Europe is just a week away and our team is excited to be participating this year in a big way! ?? Sanjay Vyas, President, Safety & Logistics and Country Head of India at Parexel, will be leading a keynote "Navigating the current & future: practical implications of GenAI in pharmacovigilance." ?? Kausik Maiti, MD, Executive Director, Safety Medical Sciences at Parexel, will host a presentation on "Leveraging real-world data for improved monitoring and evaluation of safety signals." Learn how our experts are leveraging AI and Real-World Data (RWD) to improve clinical trial efficiencies in pharmacovigilance. For more information about Sanjay and Kausik, their presentations, or to schedule a meeting with our team at the event, click here: https://lnkd.in/g-4u2WNU #WDSC #WDSC2024 #WDSCEurope2024 #Pharmacovigilance #PatientSafety #ClinicalResearch #DrugSafety #GenAI #RWD

Recapping an outstanding weekend at the Society for Clinical Research Sites (SCRS) Global Summit! Scroll through the pictures and read on for highlights from the event: ?? We were so incredibly proud to take home the Eagle Award in the CRO category for the second consecutive year! ?? We hosted our 10 "Next Generation" Site Scholarship recipients for a breakfast with program mentors and Parexel leaders to share their experiences and goals. ?? Nelly Nauman, EVP Corporate Technology and Chief Information Security Officer at Parexel, held a presentation covering emerging cyber security threats and steps sites can take to protect sensitive information. ?? Karen McIntyre MSc Clinical Trials, VP, Global Site Alliances, joined a panel discussion focused on enhancing communication between clinical sites and stakeholders. Later, she was part of an esteemed group that closed the conference by examining trends, challenges, and opportunities for clinical research sites. ?? Marlenie Moodie, PT, CCRP, Senior Manager, Regional Feasibility Network, shared insights on improving site visibility with advice on how to become a partner site of choice. ?? Shanna Nixon, Director, Site Alliances, provided invaluable input on the multifaceted nature of diversity in the workplace and strategies to create thriving, inclusive environments within organizations. Thank you to everyone who stopped by our booth, joined our sessions, and all of our site partners for another amazing event! #SCRS2024 #EagleAward #SitePartnerships #ResearchSites #ClinicalResearch

?? Mark your calendars! Join us this October for a series of insightful webinars. ?? Don't miss out on these 5 free learning opportunities with our clinical expert lineup! 1. Oct 1, 11:00 AM EDT: Accelerated Early Phase Decision Making - Insider Insights to Speed Development. https://lnkd.in/gBGMy9NS 2. Oct 2, 12:00 PM EDT: Highlights from ESMO 2024 - How does it affect drug development going forward. https://lnkd.in/ghw7GARj 3. Oct 3, 11:00 AM EDT: Leveraging post-marketing regulatory requirements to drive commercial value. https://lnkd.in/gJGj5g6n 4. Oct 23, 12:00 PM EDT: Navigating the Complexities of AML Drug Development - Expert Perspectives. https://lnkd.in/gf2EDVDV 5. Oct 29, 11:00 AM EDT: FDA Rare Disease Innovation Hub - Enhancing Collaboration and Speed. https://lnkd.in/gwd-eKib Register now to save your seat or receive a recording after the session! #Webinar #ClinicalResearch #ClinicalTrials #DrugDevelopment #EarlyPhase #ESMO24 #AML #RareDisease #FDA

"Patients are experts on their lived experiences, making them indispensable partners in drug development. As sponsors and CROs work to address unmet needs through new therapies, the patient’s voice should inform every aspect of the process." In this edition of the New Medicines, Novel Insights newsletter, Stacy Hurt ??, M.H.A., M.B.A., Chief Patient Officer, Kristina Reeder, Director, Patient Insights, and Nichola Gokool, Vice President, Customer Strategy and Innovation, Medical Communications, review the critical importance of the patient's voice throughout clinical development. Learn why this is so important in oncology trials, steps for understanding and amplifying patient perspectives, and how Parexel experts are tailoring research processes to the people the therapies are intended to serve. Read the full article and subscribe to receive the latest #NovelInsights each week! #Oncology #PatientsFirst #PatientPerspectives #PatientVoice

"Receiving this award two years in a row is a reflection of the efforts and innovative spirit of our global site-facing and site-supporting teams." - Teri Karcher Parexel has been awarded the 2024 Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category for the second consecutive year! This prestigious award underscores Parexel’s dedication to fostering strong partnerships with investigative sites and advancing patient-guided clinical research. Read the release or click through below to learn why Parexel took the prize two years in a row. ?? https://lnkd.in/eZTyP2as #SCRS2024 #EagleAward #SitePartnerships

?? What an amazing night! Parexel has been awarded the Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category at the Global Site Solutions Summit for the second consecutive year! ?? We're deeply honored to be recognized by the global site community for our commitment to strong collaboration, which is fundamental to advancing drug development and better serving patients worldwide. A huge thank you to: ? Our wonderful site partners for their trust and collaboration. ? Our colleagues who work hard and are focused on maintaining strong site relationships every day. At Parexel, we're committed to creating better experiences for patients through meaningful collaboration with our site partners. We're grateful for your support and partnership! #SCRS2024 #EagleAward #SitePartnerships #ProudToBeParexel